New drugs such as inhalable cbrticosteriods, disodium chromoglycate, and selective β2sympathomimetic agents, as well as new understanding of pathophysiologic mechanisms of older drugs, enable better pharmacologic management of the child with asthma. Emphasis is on educating patient and parents and on using doses calculated for weight of anhydrous theophylline equivalent as well as for beta agonists. Preventive environmental measures should always be used in conjunction with drug therapy.
|Original language||English (US)|
|Journal||Southern medical journal|
|Publication status||Published - Jan 1 1978|
ASJC Scopus subject areas